BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16830055)

  • 21. Biological activity of conjugates of muramyl dipeptides with batracylin derivatives.
    Trzonkowski P; Dzierzbicka K; Bociewicz J; Szmit E; Myśliwski A
    Int Immunopharmacol; 2005 Feb; 5(2):241-51. PubMed ID: 15652755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.
    Sztanke K; Tuzimski T; Rzymowska J; Pasternak K; Kandefer-Szerszeń M
    Eur J Med Chem; 2008 Feb; 43(2):404-19. PubMed ID: 17531354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between the antiproliferative effect and intracellular glutathione depletion induced by Casiopeína IIgly and cisplatin in murine melanoma B16 cells.
    Alemón-Medina R; Bravo-Gómez ME; Gracia-Mora MI; Ruiz-Azuara L
    Toxicol In Vitro; 2011 Jun; 25(4):868-73. PubMed ID: 21354300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B16 and CLS91 mouse melanoma cells susceptibility to apoptosis after vincristin treatment in vitro.
    Olszewska-Słonina D; Drewa T; Styczyński J; Olszewski K; Musiałkiewicz D
    Acta Pol Pharm; 2004; 61(2):113-21. PubMed ID: 15493293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma.
    De Stefano I; Raspaglio G; Zannoni GF; Travaglia D; Prisco MG; Mosca M; Ferlini C; Scambia G; Gallo D
    Biochem Pharmacol; 2009 Dec; 78(11):1374-81. PubMed ID: 19643088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,5-Benzodiazepines XIV. Synthesis of new substituted 9H-bis-[1,2,4]triazolo[4,3-a:3',4'-d] [1,5]benzodiazepines and relate compounds endowed with in vitro cytotoxic properties.
    Di Braccio M; Grossi G; Ceruti M; Rocco F; Loddo R; Sanna G; Busonera B; Murreddu M; Marongiu ME
    Farmaco; 2005 Feb; 60(2):113-25. PubMed ID: 15752470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic effects of C-glycosides in HOS and HeLa cell lines.
    Sanhueza CA; Mayato C; Machín RP; Padrón JM; Dorta RL; Vázquez JT
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3676-81. PubMed ID: 17482817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of transglutaminase 2 in quercetin-induced differentiation of B16-F10 murine melanoma cells.
    Forni C; Braglia R; Lentini A; Nuccetelli M; Provenzano B; Tabolacci C; Beninati S
    Amino Acids; 2009 Apr; 36(4):731-8. PubMed ID: 18688565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line.
    Serafim TL; Oliveira PJ; Sardao VA; Perkins E; Parke D; Holy J
    Cancer Chemother Pharmacol; 2008 May; 61(6):1007-18. PubMed ID: 17661039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substituted quinazolines, part 2. Synthesis and in-vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazoline analogs.
    Khalil AA; Abdel-Hamide SG; Al-Obaid AM; El-Subbagh HI
    Arch Pharm (Weinheim); 2003 Apr; 336(2):95-103. PubMed ID: 12761762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological activity of new 2-amino-8-chloro-5,5-dioxo[1,2,4]triazolo[2,3-b][1,4,2]benzodithiazines.
    Pomarnacka E; Bednarski PJ; Reszka P; Dziemidowicz-Borys E; Bieńczak A; Werel W; Hałasa R
    Eur J Med Chem; 2006 May; 41(5):633-9. PubMed ID: 16488515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-tumoral effect of native and immobilized bovine serum amine oxidase in a mouse melanoma model.
    Averill-Bates DA; Chérif A; Agostinelli E; Tanel A; Fortier G
    Biochem Pharmacol; 2005 Jun; 69(12):1693-704. PubMed ID: 15935145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of adriblastin on viability, cell cycle and apoptosis in B16 and cloudman s91 mouse melanoma cells in vitro.
    Olszewska-Słonina D; Drewa T; Czajkowski R; Olszewski K
    Acta Pol Pharm; 2004; 61(6):439-46. PubMed ID: 15794336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in-vitro and in-vivo inhibitory activity of biflorin in melanoma.
    Vasconcellos MC; Bezerra DP; Fonseca AM; Araújo AJ; Pessoa C; Lemos TL; Costa-Lotufo LV; de Moraes MO; Montenegro RC
    Melanoma Res; 2011 Apr; 21(2):106-14. PubMed ID: 21346641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synthesis and biological activities of 2,4-diamino-5-chloro-6-substituted quinazolines].
    Liu JQ; Xu XG; Chen XH; Yu AZ; Dai ZR; Zhang XP
    Yao Xue Xue Bao; 1991; 26(11):821-8. PubMed ID: 1823976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel benzotriazole derivative inhibits proliferation of human hepatocarcinoma cells by increasing oxidative stress concomitant mitochondrial damage.
    Zhang SS; Zhang HQ; Li D; Sun LH; Ma CP; Wang W; Wan J; Qu B
    Eur J Pharmacol; 2008 Apr; 584(1):144-52. PubMed ID: 18343364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinazoline-tyrphostin as a new class of antitumor agents, molecular properties prediction, synthesis and biological testing.
    Alafeefy AM; Alqasoumi SI; Ashour AE; Masand V; Al-Jaber NA; Ben Hadda T; Mohamed MA
    Eur J Med Chem; 2012 Jul; 53():133-40. PubMed ID: 22520152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antiproliferative evaluation of 4-anilino-n-methoxyfuro[2,3-b]quinoline derivatives (n=6, 7). Part 5.
    Chen YL; Lin HC; Yang CN; Lu PJ; Tzeng CC
    Chem Biodivers; 2008 Feb; 5(2):267-78. PubMed ID: 18293440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B16 and cloudman S91 mouse melanoma cells susceptibility to apoptosis after dacarbazine treatment.
    Olszewska-Słonina DM; Styczyńisk J; Drewa TA; Olszewski KJ; Czajkowski R
    Acta Pol Pharm; 2005; 62(6):473-83. PubMed ID: 16583988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.